First AD

Second AD

Lung Cancer

JAN-22-OSD1275 - /clinical/lung-cancer

The OncLive Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on non–small cell lung cancer, small cell lung cancer, mesothelioma, and more. This page features news articles, interviews in written and video format, and podcasts that focus on unmet needs, treatment advances, and ongoing research in lung cancer.

Immuno-Oncology

Immunotherapy in Lung Cancer

The OncLive Immunotherapy in Lung Cancer condition center page is a comprehensive resource for clinical news and expert insights on available and investigational immunotherapies in lung cancer. This page features news articles, interviews in written and video format, and podcasts that focus on updates with checkpoint inhibitors and the ongoing research with this type of treatment in non–small cell lung cancer and small cell lung cancer.

Practical Application of Recent Clinical Data for Immunotherapy in NSCLC

OncLive News Network®

Upfront PD-1 Inhibitor Monotherapy in Advanced NSCLC

Immunotherapy + Chemotherapy in Nonsquamous NSCLC

Combining Chemotherapy & Immunotherapy in Squamous NSCLC

TMB as a Predictive Biomarker in NSCLC

Treating Relapsed/Refractory NSCLC After I-O Therapy

Continuing/Re-Challenging With I-O Therapy in NSCLC

Experience With I-O Therapies in Second-Line NSCLC 

Immunotherapy in Locally Advanced NSCLC

Managing Pneumonitis in NSCLC

PD-L1 Expression in NSCLC

I-O Therapy Versus Surgery or Chemotherapy in NSCLC

Immunotherapy in NSCLC: Audience Q&A